Global Peripheral Arterial Disease (PAD) Therapeutics Market Report, History and Forecast 2014-2025, Breakdown Data by Companies, Key Regions, Types and Application
SKU ID : QYR-14145205 | Publishing Date : 26-Apr-2019 | No. of pages : 103
Detailed TOC of Global Peripheral Arterial Disease (PAD) Therapeutics Market Report, History and Forecast 2014-2025, Breakdown Data by Companies, Key Regions, Types and Application
Table of ContentsPeripheral Arterial Disease (PAD) Therapeutics Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025
1 Industry Overview of Peripheral Arterial Disease (PAD) Therapeutics
1.1 Peripheral Arterial Disease (PAD) Therapeutics Market Overview
1.1.1 Peripheral Arterial Disease (PAD) Therapeutics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size and Analysis by Regions
1.2.1 North America
1.2.2 Europe
1.2.3 China
1.2.4 Rest of Asia Pacific
1.2.5 Central & South America
1.2.6 Middle East & Africa
1.3 Peripheral Arterial Disease (PAD) Therapeutics Market by Type
1.3.1 Anti-Platelet Drugs
1.3.2 Dual Antiplatelet Therapy Drugs
1.3.3 Others
1.4 Peripheral Arterial Disease (PAD) Therapeutics Market by End Users/Application
1.4.1 Hospitals
1.4.2 Clinics
1.4.3 Others
2 Global Peripheral Arterial Disease (PAD) Therapeutics Competition Analysis by Players
2.1 Peripheral Arterial Disease (PAD) Therapeutics Market Size (Value) by Players (2018 and 2019)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 AstraZeneca Plc. (UK)
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Peripheral Arterial Disease (PAD) Therapeutics Revenue (Value) (2014-2019)
3.1.5 Recent Developments
3.2 Bayer HealthCare Pharmaceuticals (Germany)
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Peripheral Arterial Disease (PAD) Therapeutics Revenue (Value) (2014-2019)
3.2.5 Recent Developments
3.3 Bristol-Myers Squibb Company (US)
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Peripheral Arterial Disease (PAD) Therapeutics Revenue (Value) (2014-2019)
3.3.5 Recent Developments
3.4 Merck & Co., Inc. (US)
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Peripheral Arterial Disease (PAD) Therapeutics Revenue (Value) (2014-2019)
3.4.5 Recent Developments
3.5 Proteon Therapeutics, Inc. (US)
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Peripheral Arterial Disease (PAD) Therapeutics Revenue (Value) (2014-2019)
3.5.5 Recent Developments
3.6 Sanofi S.A. (France)
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Peripheral Arterial Disease (PAD) Therapeutics Revenue (Value) (2014-2019)
3.6.5 Recent Developments
3.7 Symic Bio, Inc. (US)
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Peripheral Arterial Disease (PAD) Therapeutics Revenue (Value) (2014-2019)
3.7.5 Recent Developments
3.8 TheraVasc Inc. (US)
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Peripheral Arterial Disease (PAD) Therapeutics Revenue (Value) (2014-2019)
3.8.5 Recent Developments
3.9 AnGes MG, Inc. (Japan)
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Peripheral Arterial Disease (PAD) Therapeutics Revenue (Value) (2014-2019)
3.9.5 Recent Developments
3.10 Athersys, Inc. (US)
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Peripheral Arterial Disease (PAD) Therapeutics Revenue (Value) (2014-2019)
3.10.5 Recent Developments
3.11 Betagenon AB (Sweden)
3.12 miRagen Therapeutics, Inc. (US)
3.13 Multi Gene Vascular Systems Ltd (Israel)
3.14 ViroMed Co. Ltd. (Korea)
4 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type and Application (2014-2019)
4.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2014-2019)
4.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2014-2019)
4.3 Potential Application of Peripheral Arterial Disease (PAD) Therapeutics in Future
4.4 Top Consumer/End Users of Peripheral Arterial Disease (PAD) Therapeutics
5 North America Peripheral Arterial Disease (PAD) Therapeutics Development Status and Outlook
5.1 North America Peripheral Arterial Disease (PAD) Therapeutics Market Size (2014-2019)
5.2 North America Peripheral Arterial Disease (PAD) Therapeutics Market Size and Market Share by Players (2018 and 2019)
6 Europe Peripheral Arterial Disease (PAD) Therapeutics Development Status and Outlook
6.1 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size (2014-2019)
6.2 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size and Market Share by Players (2018 and 2019)
7 China Peripheral Arterial Disease (PAD) Therapeutics Development Status and Outlook
7.1 China Peripheral Arterial Disease (PAD) Therapeutics Market Size (2014-2019)
7.2 China Peripheral Arterial Disease (PAD) Therapeutics Market Size and Market Share by Players (2018 and 2019)
8 Rest of Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Development Status and Outlook
8.1 Rest of Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size (2014-2019)
8.2 Rest of Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size and Market Share by Players (2018 and 2019)
9 Central & South America Peripheral Arterial Disease (PAD) Therapeutics Development Status and Outlook
9.1 Central & South America Peripheral Arterial Disease (PAD) Therapeutics Market Size (2014-2019)
9.2 Central & South America Peripheral Arterial Disease (PAD) Therapeutics Market Size and Market Share by Players (2018 and 2019)
10 Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Development Status and Outlook
10.1 Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size (2014-2019)
10.2 Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size and Market Share by Players (2018 and 2019)
11 Market Forecast by Regions, Type and Application (2019-2025)
11.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (Value) by Regions (2019-2025)
11.1.1 North America Peripheral Arterial Disease (PAD) Therapeutics Revenue and Growth Rate (2019-2025)
11.1.2 Europe Peripheral Arterial Disease (PAD) Therapeutics Revenue and Growth Rate (2019-2025)
11.1.3 China Peripheral Arterial Disease (PAD) Therapeutics Revenue and Growth Rate (2019-2025)
11.1.4 Rest of Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Revenue and Growth Rate (2019-2025)
11.1.5 Central & South America Peripheral Arterial Disease (PAD) Therapeutics Revenue and Growth Rate (2019-2025)
11.1.6 Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Revenue and Growth Rate (2019-2025)
11.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (Value) by Type (2019-2025)
11.3 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2019-2025)
12 Peripheral Arterial Disease (PAD) Therapeutics Market Dynamics
12.1 Peripheral Arterial Disease (PAD) Therapeutics Market Opportunities
12.2 Peripheral Arterial Disease (PAD) Therapeutics Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Peripheral Arterial Disease (PAD) Therapeutics Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Peripheral Arterial Disease (PAD) Therapeutics Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source
List of Figures, Tables and Charts Available in Global Peripheral Arterial Disease (PAD) Therapeutics Market Report, History and Forecast 2014-2025, Breakdown Data by Companies, Key Regions, Types and Application
List of Tables and FiguresFigure Peripheral Arterial Disease (PAD) Therapeutics Product Scope
Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) (2014-2019)
Table Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Regions in 2018
Figure North America Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure China Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure Rest of Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure Central & South America Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type in 2018
Figure Anti-Platelet Drugs Market Size (Million USD) and Growth Rate (2014-2019)
Figure Dual Antiplatelet Therapy Drugs Market Size (Million USD) and Growth Rate (2014-2019)
Figure Others Market Size (Million USD) and Growth Rate (2014-2019)
Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application in 2018
Table Key Downstream Customer in Hospitals
Figure Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) and Growth Rate in Hospitals (2014-2019)
Table Key Downstream Customer in Clinics
Figure Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) and Growth Rate in Clinics (2014-2019)
Table Key Downstream Customer in Others
Figure Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) and Growth Rate in Others (2014-2019)
Table Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) by Players (2018 and 2019)
Figure Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Players in 2018
Figure Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Players in 2019
Table AstraZeneca Plc. (UK) Basic Information List
Table Peripheral Arterial Disease (PAD) Therapeutics Business Revenue (Million USD) of AstraZeneca Plc. (UK) (2014-2019)
Figure AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Business Revenue Market Share in 2018
Table Bayer HealthCare Pharmaceuticals (Germany) Basic Information List
Table Peripheral Arterial Disease (PAD) Therapeutics Business Revenue (Million USD) of Bayer HealthCare Pharmaceuticals (Germany) (2014-2019)
Figure Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Business Revenue Market Share in 2018
Table Bristol-Myers Squibb Company (US) Basic Information List
Table Peripheral Arterial Disease (PAD) Therapeutics Business Revenue (Million USD) of Bristol-Myers Squibb Company (US) (2014-2019)
Figure Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Business Revenue Market Share in 2018
Table Merck & Co., Inc. (US) Basic Information List
Table Peripheral Arterial Disease (PAD) Therapeutics Business Revenue (Million USD) of Merck & Co., Inc. (US) (2014-2019)
Figure Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Business Revenue Market Share in 2018
Table Proteon Therapeutics, Inc. (US) Basic Information List
Table Peripheral Arterial Disease (PAD) Therapeutics Business Revenue (Million USD) of Proteon Therapeutics, Inc. (US) (2014-2019)
Figure Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Business Revenue Market Share in 2018
Table Sanofi S.A. (France) Basic Information List
Table Peripheral Arterial Disease (PAD) Therapeutics Business Revenue (Million USD) of Sanofi S.A. (France) (2014-2019)
Figure Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Business Revenue Market Share in 2018
Table Symic Bio, Inc. (US) Basic Information List
Table Peripheral Arterial Disease (PAD) Therapeutics Business Revenue (Million USD) of Symic Bio, Inc. (US) (2014-2019)
Figure Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Business Revenue Market Share in 2018
Table TheraVasc Inc. (US) Basic Information List
Table Peripheral Arterial Disease (PAD) Therapeutics Business Revenue (Million USD) of TheraVasc Inc. (US) (2014-2019)
Figure TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Business Revenue Market Share in 2018
Table AnGes MG, Inc. (Japan) Basic Information List
Table Peripheral Arterial Disease (PAD) Therapeutics Business Revenue (Million USD) of AnGes MG, Inc. (Japan) (2014-2019)
Figure AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Business Revenue Market Share in 20187
Table Athersys, Inc. (US) Basic Information List
Table Peripheral Arterial Disease (PAD) Therapeutics Business Revenue (Million USD) of Athersys, Inc. (US) (2014-2019)
Figure Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Business Revenue Market Share in 2018
Table Betagenon AB (Sweden) Basic Information List
Table miRagen Therapeutics, Inc. (US) Basic Information List
Table Multi Gene Vascular Systems Ltd (Israel) Basic Information List
Table ViroMed Co. Ltd. (Korea) Basic Information List
Table Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) by Type (2014-2019)
Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Type in 2014
Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Type in 2015
Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Type in 2016
Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Type in 2017
Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Type in 2018
Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Type in 2019
Table Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) by Application (2014-2019)
Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) by Application in 2014
Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) by Application in 2015
Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) by Application in 2015
Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) by Application in 2017
Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) by Application in 2018
Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) by Application in 2019
Table Top Consumer/End Users of Peripheral Arterial Disease (PAD) Therapeutics
Figure North America Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Table North America Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) by Players (2014-2019)
Figure North America Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Players in 2018
Figure North America Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Players in 2019
Figure Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Table Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) by Players (2014-2019)
Figure Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Players in 2018
Figure Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Players in 2019
Figure China Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Table China Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) by Players (2014-2019)
Figure China Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Players in 2018
Figure China Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Players in 2019
Figure Rest of Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Table Rest of Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) by Players (2014-2019)
Figure Rest of Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Players in 2018
Figure Rest of Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Players in 2019
Figure Central & South America Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Table Central & South America Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) by Players (2014-2019)
Figure Central & South America Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Players in 2018
Figure Central & South America Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Players in 2019
Figure Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Table Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) by Players (2014-2019)
Figure Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Players in 2018
Figure Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Players in 2019
Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) by Regions (2019-2025)
Table Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) by Regions (2019-2025)
Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Regions in 2019
Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Regions in 2025
Figure North America Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Figure Europe Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Figure China Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Figure Rest of Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Figure Central & South America Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Figure Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Table Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) by Type (2019-2025)
Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Type in 2019
Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Type in 2025
Table Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) by Application (2019-2025)
Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) by Application in 2019
Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) by Application in 2025
Keyplayers in Global Peripheral Arterial Disease (PAD) Therapeutics Market Report, History and Forecast 2014-2025, Breakdown Data by Companies, Key Regions, Types and Application
AstraZeneca Plc. (UK)Bayer HealthCare Pharmaceuticals (Germany)
Bristol-Myers Squibb Company (US)
Merck & Co., Inc. (US)
Proteon Therapeutics, Inc. (US)
Sanofi S.A. (France)
Symic Bio, Inc. (US)
TheraVasc Inc. (US)
AnGes MG, Inc. (Japan)
Athersys, Inc. (US)
Betagenon AB (Sweden)
miRagen Therapeutics, Inc. (US)
Multi Gene Vascular Systems Ltd (Israel)
ViroMed Co. Ltd. (Korea)